194 related articles for article (PubMed ID: 37968755)
1. Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis.
Luo Y; Xiang Y; Lu B; Tan X; Li Y; Mao H; Huang Q
J Orthop Surg Res; 2023 Nov; 18(1):867. PubMed ID: 37968755
[TBL] [Abstract][Full Text] [Related]
2. Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway.
Fan S; Gao X; Chen P; Li X
Life Sci; 2018 Aug; 207():205-211. PubMed ID: 29883721
[TBL] [Abstract][Full Text] [Related]
3. Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling.
Wang Y; Chen J; Chen J; Dong C; Yan X; Zhu Z; Lu P; Song Z; Liu H; Chen S
Toxicol Appl Pharmacol; 2020 Dec; 409():115333. PubMed ID: 33171191
[TBL] [Abstract][Full Text] [Related]
4. Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway.
Zhang X; Chen K; Wei B; Liu X; Lei Z; Bai X
Chem Biol Interact; 2016 Aug; 256():188-97. PubMed ID: 27387537
[TBL] [Abstract][Full Text] [Related]
5. ED-71 Prevents Glucocorticoid-Induced Osteoporosis by Regulating Osteoblast Differentiation via Notch and Wnt/β-Catenin Pathways.
Rong X; Kou Y; Zhang Y; Yang P; Tang R; Liu H; Li M
Drug Des Devel Ther; 2022; 16():3929-3946. PubMed ID: 36411860
[TBL] [Abstract][Full Text] [Related]
6. Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.
Zhou DA; Zheng HX; Wang CW; Shi D; Li JJ
BMC Musculoskelet Disord; 2014 Jul; 15():239. PubMed ID: 25027542
[TBL] [Abstract][Full Text] [Related]
7. Association of selenium intake with bone mineral density and osteoporosis: the national health and nutrition examination survey.
Peng S; Zhang G; Wang D
Front Endocrinol (Lausanne); 2023; 14():1251838. PubMed ID: 37842299
[TBL] [Abstract][Full Text] [Related]
8. Association between dietary selenium intake and the prevalence of osteoporosis: a cross-sectional study.
Wang Y; Xie D; Li J; Long H; Wu J; Wu Z; He H; Wang H; Yang T; Wang Y
BMC Musculoskelet Disord; 2019 Dec; 20(1):585. PubMed ID: 31801509
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis.
Yang L; Yang J; Pan T; Zhong X
J Endocrinol Invest; 2019 Sep; 42(9):1125-1131. PubMed ID: 30955181
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene-isothiocyanate impedes RANK/TRAF6 interaction to inhibit osteoclastogenesis, promoting osteogenesis in vitro and alleviating glucocorticoid induced osteoporosis in rats.
Kumar V; Haldar S; Ghosh S; Chauhan S; Sharma A; Dhankhar P; Kumar A; Jaiswal S; Saini S; Gupta S; Lahiri D; Roy P
Biochem Pharmacol; 2022 Dec; 206():115284. PubMed ID: 36209841
[TBL] [Abstract][Full Text] [Related]
11. Strontium gluconate potently promotes osteoblast development and restores bone formation in glucocorticoid-induced osteoporosis rats.
Dai L; Chen X; Xiong Y; Chen J; Li J; Li D; Zhou G; Zou Y; Liu T
Biochem Biophys Res Commun; 2021 May; 554():33-40. PubMed ID: 33774277
[TBL] [Abstract][Full Text] [Related]
12. The role of Serpina3n in the reversal effect of ATRA on dexamethasone-inhibited osteogenic differentiation in mesenchymal stem cells.
Jiang HT; Deng R; Deng Y; Nie M; Deng YX; Luo HH; Yang YY; Ni N; Ran CC; Deng ZL
Stem Cell Res Ther; 2021 May; 12(1):291. PubMed ID: 34001245
[TBL] [Abstract][Full Text] [Related]
13. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
Li G; Bu J; Zhu Y; Xiao X; Liang Z; Zhang R
Int J Clin Exp Pathol; 2015; 8(12):15684-95. PubMed ID: 26884838
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of necrostatin-1 on glucocorticoid-induced osteoporosis in rats.
Feng M; Zhang R; Gong F; Yang P; Fan L; Ni J; Bi W; Zhang Y; Wang C; Wang K
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():455-62. PubMed ID: 25220755
[TBL] [Abstract][Full Text] [Related]
15. Z-Guggulsterone attenuates glucocorticoid-induced osteoporosis through activation of Nrf2/HO-1 signaling.
Xu Y; Guan J; Xu J; Chen S; Sun G
Life Sci; 2019 May; 224():58-66. PubMed ID: 30905781
[TBL] [Abstract][Full Text] [Related]
16. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats.
Yang Y; Nian H; Tang X; Wang X; Liu R
J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481
[TBL] [Abstract][Full Text] [Related]
17.
Yang Y; Yu T; Tang H; Ren Z; Li Q; Jia J; Chen H; Fu J; Ding S; Hao Q; Xu D; Song L; Sun B; Sun F; Pei J
Front Pharmacol; 2020; 11():731. PubMed ID: 32508652
[TBL] [Abstract][Full Text] [Related]
18. Orcinol glucoside targeted p38 as an agonist to promote osteogenesis and protect glucocorticoid-induced osteoporosis.
He XY; Zhao WL; Yao LP; Sun P; Cheng G; Liu YL; Yu Y; Liu Y; Wang TJ; Zhang QY; Qin LP; Zhang QL
Phytomedicine; 2023 Oct; 119():154953. PubMed ID: 37573809
[TBL] [Abstract][Full Text] [Related]
19. Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway.
Li S; Cui Y; Li M; Zhang W; Sun X; Xin Z; Li J
J Invest Surg; 2023 Dec; 36(1):2154578. PubMed ID: 36521840
[TBL] [Abstract][Full Text] [Related]
20. FK506 ameliorates osteoporosis caused by osteoblast apoptosis via suppressing the activated CaN/NFAT pathway during oxidative stress.
Jie J; Li W; Wang G; Xu X
Inflamm Res; 2021 Jul; 70(7):789-797. PubMed ID: 34165588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
